PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Precision Pharmacotherapy Research & Development Institute, Tabula Rasa HealthCare, Orlando, Florida, USA.\', \'Cambia Health Solutions - Case Management at Regence BlueShield, Tacoma, Washington, USA.\', \'Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/cts.13025
?:hasPublicationType
?:journal
  • Clinical and translational science
is ?:pmid of
?:pmid
?:pmid
  • 33786990
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.669
?:rankingScore_hIndex
  • 31
is ?:relation_isRelatedTo_publication of
?:title
  • Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients\' drug regimens: A drug safety simulation study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all